DIRECT DETERMINATION OF NICOTINE IN ANTISMOKING PHARMACEUTICAL PRODUCTS AND IN TOBACCO USING AN INHIBITION BIOSENSOR
- 30 April 2001
- journal article
- Published by Taylor & Francis in Analytical Letters
- Vol. 34 (6) , 855-866
- https://doi.org/10.1081/al-100103597
Abstract
A bienzymatic inhibition biosensor, consisting of a hydrogen peroxide amperometric electrode coupled to a functionalised nylon membrane chemically bonding the enzymes butyrylcholinesterase and choline oxidase and using butyrylcholine as substrate, was prepared and tested for the analysis of nicotine. The system was applied to the analysis of several pharmaceutical formulations containing nicotine used to treat addiction and to determine the nicotine content of different types of commercial tobacco.Keywords
This publication has 13 references indexed in Scilit:
- A new organic phase enzyme electrode for the analysis of organophosphorus pesticides and carbamatesAnalytica Chimica Acta, 1999
- Further developments in toxicity cell biosensorsSensors and Actuators B: Chemical, 1997
- Immobilised yeast cells biosensor for total toxicity testingScience of The Total Environment, 1995
- Determination of compounds with anticholinesterase activity in commercial drugs by a new enzyme sensorJournal of Pharmaceutical and Biomedical Analysis, 1992
- Butyrylcholine enzyme sensor for determining organophosphorus inhibitorsBioelectrochemistry and Bioenergetics, 1991
- Liquid membrane electrodes for the selective determination of nicotine in cigarette smokeThe Analyst, 1989
- Electrochemical Determination of Electroinactive Medicines with Nafion-Coated ElectrodesChemistry Letters, 1987
- Potentiometric determination of nicotine in tobacco products with a nicotine-sensitive liquid membrane electrodeAnalytica Chimica Acta, 1981
- Application of Gas Chromatography to Street Drug AnalysisClinical Toxicology, 1977
- Dosage physico-chimique de la nicotineAnalytica Chimica Acta, 1951